OneCell Diagnostics Inc.
India
- Pune , Maharashtra
- 22/11/2024
- Series A
- $16,000,000
OneCell Diagnostics, Inc. is a Precision Oncology Liquid Biopsy Diagnostics Company focused on developing the 1st-in-Class, Circulating Tumor Cell (CTC)-based, Single-Cell Multi-omics Lab Developed Tests for applications in clinical cancer care & early-stage clinical trials for Biotech/Pharma companies.
OneCell Diagnostics, Inc. is a joint venture between two companies with innovative technologies: Actorius Innovations and Research Pvt Ltd, a leading provider of CTC Tests in India, and Indx.ai, a Silicon Valley based innovative software company specialising in Multi-omics Biomarker Data Analytics.
- Industry Biotechnology Research
- Website https://www.onecelldx.com/
- LinkedIn https://www.linkedin.com/company/onecelldx/
Related People
Mohan UttarwarCo Founder
United States -
Cupertino, California
* Serial entrepreneur who co-founded 5 companies, raised over $50M in investment and created the share-holder value of over $500M.
* Strategic thinker who can identify holes in the marketplace and attract a great team to build innovative products & solutions to fill those holes and get the first mover advantage.
* Visionary with a mission of touching the lives of 1B patients and making a societal impact around the world.
* Angel Investor with real world experience of helping entrepreneurs building business & creating value
DISA Technologies, Inc. | $33,000,000 | (May 1, 2026)
Jupid | $840,000 | (May 1, 2026)
Dreambase | $3,700,000 | (May 1, 2026)
Creati AI | $20,000,000 | (May 1, 2026)
Manifest OS | $60,000,000 | (May 1, 2026)
Iterative Health | $77,000,000 | (May 1, 2026)
Blomma | $5,000,000 | (May 1, 2026)
Illuminant Surgical | $8,400,000 | (May 1, 2026)
BioOrbit | $13,334,811 | (May 1, 2026)
Parallel Web Systems | $100,000,000 | (Apr 30, 2026)
Fence | $20,000,000 | (Apr 30, 2026)
Certifyde | $2,000,000 | (Apr 30, 2026)